Disease/Condition
508 Clinical Trials
10+ Countries
Crohn's Disease Clinical Trials Database - Free Access to 508 Studies
Access comprehensive clinical trial information for Crohn's Disease through Pure Global AI's free database. This collection includes 508 clinical trials across multiple phases including N/A, Phase 3, Phase 2. Currently, 43 trials are actively recruiting participants.
Research for Crohn's Disease is being conducted in United States of America, Israel, China and 7+ other countries. Leading sponsors include AbbVie and Abbott. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Free Database
Powered by Pure Global AI
840K+ Global Trials
Updated Daily
By Phase
N/A
183Phase 3
110Phase 2
106Phase 4
43Early Phase 1
29By Status
Completed
270Terminated
74Unknown
54Recruiting
43Not yet recruit...
27Top Countries
United States of America91
Israel22
China20
France20
Japan18
Top Sponsors
AbbVie25
Abbott14
Takeda13
UCB Pharma12
GlaxoSmithKline10
Recent Trials
Latest clinical trials for Crohn's Disease
2014-004531-39
A Study of Adalimumab for the Maintenance of Clinical Remission in Japanese Subjects With Crohn's Disease.
Abbott Deutschland GmbH & Co. ...
SLCTR_2018_029
Phase 3
Recruiting
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease (Diversity1)
Gilead Sciences, IncAustralia, Austria, Belgium, Bulgaria, Canada, Croatia, Czech Republic, France, Georgia, Germany, Gr
2015-004121-13
A Multicenter Open-label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Investigate Efficacy, Safety and Pharmacokinetics after Dose Escalation in Japanese Subjects with Crohn's Disease
AbbVie GK
2014-004560-38
The purpose of this study is to demonstrate the efficacy and safety of adalimumab for the induction of clinical remission in Japanese subjects with Crohn's disease.
Abbott Deutschland GmbH & Co. ...
NCT06408935
Phase 3
Recruiting
Transmural Healing and Disease-Modifying Effect of Guselkumab in Crohn's Disease Patients
Janssen-Cilag Ltd.Israel,Taiwan
NCT06362863
Not yet recr...
Evaluation of Enteral Nutrition Biscuits for Inducing Remission in Moderate-to-severe Crohn's Disease
Ping An
NCT06332534
Phase 3
Not yet recr...
Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease
AbbVie
NCT06362174
Recruitment ...
Capsule & Omics for pRedicting Exacerbation of Crohn's Disease
Sheba Medical CenterIsrael
NCT06249555
Not yet recr...
VOICE-Early Response to Vedolizumab and Ustekinumab in Participants With Crohn's Disease: A Prospective Observational Study
Alimentiv Inc.
NCT06233461
Phase 2
Not yet recr...
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
Takeda
NCT06227910
Phase 3
Not yet recr...
A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease
Takeda
NCT06244849
Not yet recr...
TOward a Better Understanding of the autoPhagy Machinery for the Identification of Potential Novel Biomarkers and Therapeutic Targets in Crohn's Disease - TOPIC Study
Hospices Civils de LyonFrance
NCT06299631
Completed
Endoscopic Relapse Risks Evaluation After Ileocolic Resection for Crohn's Disease
University Hospital, Montpelli...France
NCT06126146
Recruiting
An Observational Study to Assess Participant-Reported Real-World Experience of Risankizumab On-body Injector (OBI) for the Treatment of Crohn's Disease in Adult Participants in the United Kingdom (UK)
AbbVieUnited Kingdom
NCT06124287
Not yet recr...
MRE Predictors of Disease Relapse After Stopping Biologics
University College, London
NCT06063967
Phase 3
Recruiting
A Study to Assess Adverse Events and Change in Disease Activity of Risankizumab Subcutaneous Induction Treatment for Moderately to Severely Active Crohn's Disease.
AbbVieUnited States of America
jRCT2031230352
Not yet recr...
Untitled Trial
Janssen Pharmaceutical K.K.Australia;Belgium;Brazil;Canada;Switzerland;Czech;Spain;France;United Kingdom of Great Britain;Israe
NCT06045754
Phase 4
Not yet recr...
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
TakedaUnited States of America
NCT06064864
Not yet recr...
Efficacy and Safety of Formulation Switching Between SC Infliximab and IV Infliximab in Patients With CD
Asan Medical CenterSouth Korea
NCT06053424
Phase 1
Recruiting
Positron Emission Tomography Study of Changes in [11C]AZ14132516 Uptake Following Administration of AZD7798 to Healthy Participants and Patients With Crohn's Disease
AstraZenecaSweden
About Crohn's Disease Research
Pure Global AI provides free access to 508 clinical trials studying Crohn's Disease, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include AbbVie, Abbott, Takeda, among others.
Quick Facts
Total Trials508
Countries10+
Sponsors10+
Recruiting43